About Us

Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

A Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Social Media

Bluesky • Facebook • Instagram • LinkedIn • YouTube

Meet the Laser Focus World Team

Editorial

Sales

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology
My Watchlist
Indicators
Industrial Laser Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Palantir Stock Has It all… Except the Analysts' Support

By: MarketBeat

Palantir stock price

Palantir Technologies (NYSE: PLTR) stock is gaining traction and may advance another 50% or more in the next few months. The company has a solid product, growing demand, deepening penetration and widening margins that can all be blamed on its utility. The company is the leading provider of data gathering and mining, using the platform to detect and prevent threats, internal and external, insight into efficiency, and product development. This company has everything except the analyst's support regarding the stock price. 

For some reason, analysts continue to nay-say Palantir despite a solid Q4 report. The company reported better-than-expected revenue, accelerated growth on ramping up commercial business, and reversed a loss in the previous year, which should have lifted sentiment. As it is, the analysts began to lift their price targets but low-balled the technology stock and kept it pegged at Reduce.

Sell-siders underestimate Palantir … for a reason?

At face value, it looks like Palantir is overvalued, but it has been suggested by Keith Fitz-Gerals that sell-side money is trying to shake out weak hands. Keeping the price target low and the sentiment at Reduce, retail investors may get spooked and sell out the stock. In that scenario, the share price could plummet, providing an entry that has yet to appear. The Q4 results suggest that business will continue accelerating in 2024 and outperform arguably low-ball estimates for 2024. 

The guidance for 2024 is good but also cautious. The company forecasts only 20% growth on top of 2023’s high-teen advance, which is discounting momentum and demand for AI services worldwide. The 30% growth in commercial business and expanding end markets are reasons to expect outperformance. Palantir is moving into health care, energy, and manufacturing, with nearly limitless applications. Competitors like Snowflake and Datadog are growing at much faster rates. 

Analysts Sell, But Institutions Are Buying 

Analysts have the stock pegged at Sell, but institutions are buying the stock. Institutions own about 35%, which is not a large amount, but their activity ramped in Q3 2023 and remained strong into Q1 2024 with no signs of slowing. The quarter-to-date tally for Q1 2024 has already surpassed the Q4 2024 tally and may continue strongly through the quarter's end. The largest holder is Vanguard Group’s collective holding at nearly 9%, primarily publicly traded funds, but ownership is broad and includes a significant amount of private capital. 

HSBC downgraded Palantir to Hold following the Q4 release, citing valuation as a primary factor. However, trading at 16X earnings and expected (by HSBC) to grow at a 20%+ CAGR over the next four years, its valuation doesn’t appear to be a problem for most. 

Ironically, analysts are lifting their price targets. Marketbeat.com tracks seven revisions following the Q4 release, including five boosted price targets and two upgrades, but consensus still lags the market. The consensus estimate assumes a 30% decline in the stock price, which is unlikely given the technical outlook.

The Technical Outlook: Palantir Confirms a Critical Pivot Point

The chart of PLTR stock is a textbook example of IPO pop followed by implosion, bottom and reversal. The bottom is marked by a Head & Shoulders Pattern and a ramp in trading volume that coincides with the FQ1 results in 2023, which proved the move to open services to commercial business was good. Since then, trading volume has remained elevated and lifted the price action by 175%. Now, Palantir has crossed a critical pivot point at the mid-point of its trading range and is heading higher following a continuation signal. 

The next target for this stock is near $29 and may be reached by late spring. Assuming the market can advance above that point, the door is open to $38.50 and a retest of the all-time high. Assuming the Q1 results align with 2023 trends and the forecast for 2024, the market should have no trouble moving to a new high with or without analysts' support. If the news is good enough, the analysts change their tune and get on board this trade, and buying could accelerate again and move the price to a new all-time highs.

More News

View More
Pfizer is Locking in New Growth Through a New Acquisition
Via MarketBeat
Topics Artificial Intelligence
Tickers MTSR PFE
Copper Giant Freeport Slumps but Analysts See 33% Upside
Via MarketBeat
Tickers FCX SCCO
The BYD Opportunity: Tesla-Like Growth at a Fraction of the Price
Via MarketBeat
Topics Electric Vehicles
Tickers BYDDY LI TSLA
3 Reasons CoreWeave Could Be the Hottest AI Stock in Q4
Via MarketBeat
Topics Artificial Intelligence
Tickers CRWV NVDA
Accenture: Undervalued GenAI Leader or Snake Eating its Own Tail?
Via MarketBeat
Tickers ACN IBM
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.